224 related articles for article (PubMed ID: 27045209)
1. Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes.
Chamorro C; Mencía A; Almarza D; Duarte B; Büning H; Sallach J; Hausser I; Del Río M; Larcher F; Murillas R
Mol Ther Nucleic Acids; 2016 Apr; 5(4):e307. PubMed ID: 27045209
[TBL] [Abstract][Full Text] [Related]
2. Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells.
Mencía Á; Chamorro C; Bonafont J; Duarte B; Holguin A; Illera N; Llames SG; Escámez MJ; Hausser I; Del Río M; Larcher F; Murillas R
Mol Ther Nucleic Acids; 2018 Jun; 11():68-78. PubMed ID: 29858091
[TBL] [Abstract][Full Text] [Related]
3. Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing.
Bonafont J; Mencía A; Chacón-Solano E; Srifa W; Vaidyanathan S; Romano R; Garcia M; Hervás-Salcedo R; Ugalde L; Duarte B; Porteus MH; Del Rio M; Larcher F; Murillas R
Mol Ther; 2021 Jun; 29(6):2008-2018. PubMed ID: 33609734
[TBL] [Abstract][Full Text] [Related]
4. Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs.
Osborn MJ; Newby GA; McElroy AN; Knipping F; Nielsen SC; Riddle MJ; Xia L; Chen W; Eide CR; Webber BR; Wandall HH; Dabelsteen S; Blazar BR; Liu DR; Tolar J
J Invest Dermatol; 2020 Feb; 140(2):338-347.e5. PubMed ID: 31437443
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.
Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F
Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675
[TBL] [Abstract][Full Text] [Related]
6. Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.
Izmiryan A; Ganier C; Bovolenta M; Schmitt A; Mavilio F; Hovnanian A
Mol Ther Nucleic Acids; 2018 Sep; 12():554-567. PubMed ID: 30195791
[TBL] [Abstract][Full Text] [Related]
7. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl S; Peking P; Kocher T; Murauer EM; Larcher F; Del Rio M; Duarte B; Steiner M; Klausegger A; Bauer JW; Reichelt J; Koller U
Mol Ther; 2017 Nov; 25(11):2573-2584. PubMed ID: 28800953
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.
Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H
Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033
[TBL] [Abstract][Full Text] [Related]
9. Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients.
Ryoo YW; Kim BC; Lee KS
J Dermatol Sci; 2001 Jun; 26(2):125-32. PubMed ID: 11378329
[TBL] [Abstract][Full Text] [Related]
10. A non-viral and selection-free
Kocher T; Bischof J; Haas SA; March OP; Liemberger B; Hainzl S; Illmer J; Hoog A; Muigg K; Binder HM; Klausegger A; Strunk D; Bauer JW; Cathomen T; Koller U
Mol Ther Nucleic Acids; 2021 Sep; 25():237-250. PubMed ID: 34458008
[TBL] [Abstract][Full Text] [Related]
11. Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by
García M; Bonafont J; Martínez-Palacios J; Xu R; Turchiano G; Svensson S; Thrasher AJ; Larcher F; Del Rio M; Hernández-Alcoceba R; Garín MI; Mencía Á; Murillas R
Mol Ther Methods Clin Dev; 2022 Dec; 27():96-108. PubMed ID: 36212909
[TBL] [Abstract][Full Text] [Related]
12. Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.
Wang X; Alshehri F; Manzanares D; Li Y; He Z; Qiu B; Zeng M; A S; Lara-Sáez I; Wang W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884578
[TBL] [Abstract][Full Text] [Related]
13. Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa.
Pasmooij AM; Garcia M; Escamez MJ; Nijenhuis AM; Azon A; Cuadrado-Corrales N; Jonkman MF; Del Rio M
J Invest Dermatol; 2010 Oct; 130(10):2407-11. PubMed ID: 20574443
[TBL] [Abstract][Full Text] [Related]
14. Cytosine Deaminase Base Editing to Restore
Naso G; Gkazi SA; Georgiadis C; Jayarajan V; Jacków J; Fleck R; Allison L; Ogunbiyi OK; McGrath JA; Ilic D; Di WL; Petrova A; Qasim W
JID Innov; 2023 May; 3(3):100191. PubMed ID: 37213713
[TBL] [Abstract][Full Text] [Related]
15. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
Takashima S; Shinkuma S; Fujita Y; Nomura T; Ujiie H; Natsuga K; Iwata H; Nakamura H; Vorobyev A; Abe R; Shimizu H
J Invest Dermatol; 2019 Aug; 139(8):1711-1721.e4. PubMed ID: 30831133
[TBL] [Abstract][Full Text] [Related]
16. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A
J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells.
Jacków J; Guo Z; Hansen C; Abaci HE; Doucet YS; Shin JU; Hayashi R; DeLorenzo D; Kabata Y; Shinkuma S; Salas-Alanis JC; Christiano AM
Proc Natl Acad Sci U S A; 2019 Dec; 116(52):26846-26852. PubMed ID: 31818947
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
[TBL] [Abstract][Full Text] [Related]
19. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
20. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
